24-Oct-23 |
Buy |
Robert Coles |
9.00p | 222,211 |
£19,998.99 |
01-Sep-23 |
Buy |
Thomas Ilube |
8.10p | 24,691 |
£1,999.97 |
24-Oct-23 |
Buy |
Robert Coles |
9.00p | 222,211 |
£19,998.99 |
01-Sep-23 |
Buy |
Thomas Ilube |
8.10p | 24,691 |
£1,999.97 |
Thomas Ilube |
14,667,260 |
£748,030 |
David Secher |
26,365 |
£1,345 |
Gresham House Asset Management Limited |
17,437,243 |
£889,299 |
Canaccord Genuity Group Inc |
10,703,501 |
£545,879 |
Helium Rising Stars Fund |
4,235,390 |
£216,005 |
Brenlen Jinkens |
3,914,500 |
£199,640 |
Hargreave Hale AIM VCT |
3,448,300 |
£175,863 |
Steven Gee |
2,460,900 |
£125,506 |
Maurice Zimmerman |
2,329,400 |
£118,799 |
Nano-Cap Growth Fund |
2,196,700 |
£112,032 |
Share Nominees Limited |
2,096,800 |
£106,937 |
John Taysom |
1,472,100 |
£75,077 |
GPIM Limited |
1,411,300 |
£71,976 |
CEO |
Thomas Ilube |
CFO |
Mary Dowd |
Top of Page
You are here:
research